Block A, Building 2, No.158 Xinjunhuan Road, Pujiang Town,Minhang District, Shanghai,China
FeiLuMing-FeiDiKe
Application: Advanced stage lung cancer patients
Product Advantages:
100% coverage of the 50 targeting drugs approved by FDA / NMPAs and 246 drug targeting sites applied in clinical trials, providing more drug opportunities for patients
30 immune efficacy positive / negative - correlated genes especially tailored-made for lung cancer patients, providing reference for efficacy in immunotherapy
FeiLuMing(肺路明)：Longer than whole length, with full exon coverage, high-density shingled probe design, 60bp of double-ended extension, accurately and comprehensively capturing relevant drug-targeting sites.
FeiDiKe(肺迪科)：35000X saturation sequencing, LOD of 0.01%, increasing medication opportunities for patients by checking out more than 36% of ctDNA low-frequency mutation points.
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
